跳至主要内容
临床试验/ISRCTN37161699
ISRCTN37161699已完成未知

A randomised controlled trial of adjunctive plasma exchange in patients with newly diagnosed multiple myeloma and acute renal failure

Imperial College London (UK)0 个研究点目标入组 280 人开始时间: 2000年9月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
280

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Patients with newly diagnosed myeloma and acute renal failure, aged 18 years or over
  • Added as of 10/12/2009:
  • 1. Newly diagnosed myeloma
  • 2. Acute renal failure (creatinine greater than 500 mmol/l, urine output less than 400 ml/d or requiring dialysis)
  • 3. Aged 18 years or over, either sex
  • 4. Written informed consent
  • 5. No previous chemotherapy for myeloma
  • 6. No significant intrinsic renal disease unrelated to myeloma

排除标准

  • Does not comply with above inclusion criteria

研究者

发起方
Imperial College London (UK)

相似试验